2027 Summer Intern - Translational Pharmacokinetics and Pharmacodynamics, Modeling and Simulation
Genentech
Summary
This intern position is in the Translational Pharmacokinetics & Pharmacodynamics (tPKPD) Department within Development Sciences. The tPKPD department applies preclinical and computational models (in silico, in vitro, or in vivo) to determine the pharmacokinetics and pharmacodynamics of therapeutics, informing lead molecule selection, dosing regimen optimization, and translation of molecules from research into early clinical development across oncology, immunology, ophthalmology, neuroscience, and cardiovascular, renal and metabolic (CVRM) diseases. Within tPKPD, the Modeling and Simulation group builds mechanistic, quantitative systems pharmacology (QSP) models that link drug pharmacology to patient outcomes.
Job description
Department Summary
This intern position is in the Translational Pharmacokinetics & Pharmacodynamics (tPKPD) Department within Development Sciences. The tPKPD department applies preclinical and computational models (in silico, in vitro, or in vivo) to determine the pharmacokinetics and pharmacodynamics of therapeutics, informing lead molecule selection, dosing regimen optimization, and translation of molecules from research into early clinical development across oncology, immunology, ophthalmology, neuroscience, and cardiovascular, renal and metabolic (CVRM) diseases. Within tPKPD, the Modeling and Simulation group builds mechanistic, quantitative systems pharmacology (QSP) models that link drug pharmacology to patient outcomes.
The Opportunity
Join our Translational Pharmacokinetics/Pharmacodynamics team for 12 weeks to support cutting-edge research in drug development and single cell transcriptomic data analysis.
- Extend an existing neurodegenerative disease platform model to include various cell types, incorporating single-cell transcriptomic data.
- Analyze single-cell expression datasets to uncover relationships between drug exposure, receptor expression, and cell distribution in tissues.
- Predict regional differences in drug efficacy across tissues using Quantitative Systems Pharmacology (QSP) and agentic AI workflows for modeling and simulation.
- Contribute directly to pipeline programs and help develop techniques that support future therapeutic programs.
Who You Are
Required Education
You meet one of the following criteria:
- Must be pursuing a Master's Degree (enrolled student).
- Must have attained a Master's Degree.
- Must be pursuing a PhD (enrolled student).
Required Majors: Quantitative Systems Pharmacology (QSP), chemical/electrical/mechanical/biomedical engineering, applied mathematics, computer science, or a related pharmaceutical sciences field.
Required Skills
- Hands-on experience with computational modeling platforms such as MATLAB/Simbiology, R, or Python.
- Understanding of computational modeling of biological systems, agentic AI workflows, and pharmacokinetics/pharmacodynamics principles.
Preferred Knowledge, Skills, And Qualifications
- Excellent communication, collaboration, and interpersonal skills.
- Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion.
Requirements
- Must be pursuing a Master's Degree (enrolled student), have attained a Master's Degree, or be pursuing a PhD (enrolled student)
- Required majors: Quantitative Systems Pharmacology (QSP), chemical/electrical/mechanical/biomedical engineering, applied mathematics, computer science, or a related pharmaceutical sciences field
- Hands-on experience with computational modeling platforms such as MATLAB/SimBiology, R, or Python
- Understanding of computational modeling of biological systems, agentic AI workflows, and pharmacokinetics/pharmacodynamics principles
- Excellent communication, collaboration, and interpersonal skills
Benefits
- Paid Internship
- Stipend
- Paid Holiday Time Off
Company overview
Genentech, founded in 1976 and now a member of the Roche Group, is widely recognized as the pioneer of the biotechnology industry. The company has been at the forefront of scientific innovation for nearly 50 years, using human genetic information to develop novel medicines for serious and life-threatening diseases. Genentech's transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. With over 10,000 employees, the company operates from its South San Francisco headquarters and maintains a strong focus on oncology, immunology, neuroscience, ophthalmology, and infectious diseases. Genentech continues to pursue groundbreaking science while maintaining its startup spirit within the Roche organization, consistently delivering on its promise to improve patients' lives through innovative biopharmaceutical solutions.